Intravenous rtPA thrombolysis in acute ischemic stroke

Acta Neurologica Belgica

Volumn 101, Issue 2, 2001, Pages 88-95

  Laloux, Patrice ^a  

^a UNIVERSITY HOSPITAL OF MONT GODINNE   (Belgium)

Author keywords

Alteplase; Cerebral ischemia; Stroke; Therapy; Thrombolysis

Indexed keywords

ALTEPLASE;

BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CLINICAL PRACTICE; CLINICAL PROTOCOL; CLINICAL TRIAL; DATA BASE; DRUG EFFICACY; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; FIBRINOLYTIC THERAPY; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; META ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SELECTION; REVIEW;

EID: 0034890170     PISSN: 03009009     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (73)

1. AMES A., WRIGHT R. L., KOWADA M., THURSTON J. M., MAJNO G. Cerebral ischemia. II The noreflow phenomenon. Am. J. Path., 1968, 52 : 437-447.
2. BAIRD A. E., BENFIELD A., SCHLAUG G., SIEWERT B., LOVBLAD K. O. et al. Enlargement of human cerebral ischemic lesion volumes measured by diffusion-weighted magnetic resonance imaging. Ann. Neurol., 1997, 41 : 581-589.
3. BARON J. C., VON KUMMER R., DEL ZOPPO G. J. Treatment of acute ischemic stroke : Challenging the concept of a rigid and universal time window. Stroke, 1995, 26 : 2219-2221.
4. BATH PH. Alteplase not yet proven for acute ischaemic stroke. Lancet, 1998, 352 : 1238-1239.
5. BOZZAO L., ANGELONI U., BASTIANELLO S., FANTOZZI L. M., PIERALLINI A. et al. Early angiographic and CT findings in patients with hemorrhagic infarction in the distribution of the middle cerebral artery. Am. J. Neuroradiol., 1991, 12 : 1115-1121.
6. BOZZAO L., BASTIANELLO S., FANTOZZI L. M., ANGELONI U., ARGENTINO C. et al. Correlation of angiographic and sequential CT findings in patients with evolving cerebral infarction. Am. J. Neuroradiol., 1989a, 10 : 1215-1222.
7. BOZZAO L., FANTOZZI L. M., BASTIANELLO S., BOZZAO A., FIESCHI C. Early collateral blood supply and late parenchymal brain damage in patients with middle cerebral artery occlusion. Stroke, 1989b, 20 : 735-740.
8. BRANSTON N. M., BELL B. A., HUNSTOCK A., SYMON L. Time and flow as factors in the formation of postischemic edema in primate cortex. Adv. Neurol., 1980, 28 : 291-298.
9. BROTT T. G., HALEY E. C. J., LEVY D. E., BARSAN W., BRODERICK J. et al. Urgent therapy for stroke : Part I. Pilot study of tissue plasminogen activator administered within 90 minutes. Stroke, 1992, 23 : 632-640.
10. BUCHAN A. M., BARBER P. A., NEWCOMMON N., KARBALAI H. G., DEMCHUK A. M. et al. Effectiveness of t-PA in acute ischemic stroke : outcome relates to appropriateness. Neurology, 2000, 54 : 679-684.
11. CARTER L. P., GUTHKELCH A. N., OROZCO J., TEMELTAS O. Influence of tissue plasminogen activator and heparin on cerebral ischemia in a rabbit model. Stroke, 1992, 23 : 883888.
12. CHIU D., KRIEGER D., VILLAR-CORDOVA C., KASNER S. E., MORGENSTERN L. B. et al. Intravenous Tissue-Plasminogen Activator for Acute Ischemic Stroke : Feasibility, Safety, and Efficacy in the First Year of Clinical Practice. Stroke, 1998, 29 : 18-22.
13. CLARK W. M., ALBERS G. W., MADDEN K. P., HAMILTON S. The rtPA (Alteplase) 0-to 6-hour acute stroke trial, part A (A0276g) : results of a double-blind, placebo-controlled, multicenter study. Stroke, 2000, 31 : 811-816.
14. CLARK W. M., MADDEN K. P., LYDEN P. D., ZIVIN J. A. Cerebral hemorrhagic risk of aspirin or heparin therapy with thrombolytic treatment in rabbits. Stroke, 1991, 22 : 872-876.
15. CLARK W. M., WISSMAN S., ALBERS G. W., JHAMANDAS J. H., MADDEN K. P. et al. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study : a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. J. Am. Med. Assoc., 1999, 282 : 2019-2026.
16. DALAL P. M., SHAH P. M., SHETH S. C., DESHPANDE C. K. Cerebral embolism. Angiographic observations on spontaneous clot lysis. Lancet, 1965, 1 : 61-64.
17. DAVIS S. M., CHUA M. G., LICHTENSTEIN M., ROSSITER S. C., BINNS D. et al. Cerebral hypoperfusion in stroke prognosis and brain recovery. Stroke, 1993, 24 : 1691-1696.
18. DEL ZOPPO G. J., COPELAND B. R., ANDERCHEK K., HACKE W., KOSIOL J. A. Hemorrhagic transformation following tissue plasminogen activator in experimental cerebral infarction. Stroke, 1990, 21 : 596-601.
19. GROND M., RUDOLF J., SCHMÜLLING S., STENZEL C., NEVELING M. et al. Early intravenous thrombolysis with recombinant tissue-type plasminogen activator in vertebrobasilar ischemic stroke. Arch. Neurol., 1998a, 55 : 466-469.
20. GROND M., STENZEL C., SCHMÜLLING S., RUDOLF J., NEVELING M. et al. Early intravenous thrombolysis for acute ischemic stroke in a community-based approach. Stroke, 1998b, 29 : 1544-1549.
21. HACKE W., KASTE M., FIESCHI C., TONI D., LESAFFRE E. et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke : The European Cooperative Acute Stroke Study (ECASS). J. Am. Med. Assoc., 1995, 274 : 1017-1025.
22. HACKE W., KASTE M., FIESCHI C., VON KUMMER R., DAVALOS A. et al. Randomized double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet, 1998, 352 : 1245-1251.
23. HALEY E. C. J., LEVY D. E., BROTT T. G., SHEPPARD G. L., WONG M. C. W. et al. Urgent therapy for stroke : Part II. Pilot study of tissue plasminogen activator administered 91-180 minutes from onset. Stroke, 1992, 23 : 641-645.
24. HERDERSCHEE D., LIMBURG M., HIJDRA A., KOSTER E. Recombinant tissue plasminogen activator in two patients with basilar artery occlusion. J. Neurol. Neurosurg. Psychiatry, 1991, 54 : 71-73.
25. HOMMEL M., VIALLET F., BONNEFOI KYRIACOU D., GAYRAUD D., KIEGEL P. et al. Thrombolytic therapy with streptokinase in acute ischemic stroke. New Engl. J. Med., 1996, 335 : 145-150.
26. HUEMER M., NIEDERWIESER V., LADURNER G. Thrombolytic treatment for acute occlusion of the basilar artery. J. Neurol. Neurosurg. Psychiatry, 1995, 58 : 227-228.
27. ITO U., OHNO K., NAKAMURA R., SUGANUMA F., INABA Y. Brain edema during ischemia and after restoration of blood flow : measurement of water, sodium, potassium content and plasma protein permeability. Stroke, 1979, 10 : 542-547.
28. JORGENSEN H. S., NAKAYAMA H., KAMMERSGAARD L. P., RAASCHOU H. O., OLSEN T. S. Predicted impact of intravenous thrombolysis on prognosis of general population of stroke patients : simulation model. Br. Med. J., 1999, 319 : 288-289.
29. LEVY D. E., BROTT T. G., HALEY E. C. J., MARLER J. R., SHEPPARD G. L. et al Factors related to intracranial hematoma formation in patients receiving tissue-type plasminogen activator for acute ischemic stroke. Stroke, 1994, 25 : 291-297.
30. LYDEN P. D., MADDEN K. P., CLARK W. M., SASSE K. C., ZIVIN J. A. Incidence of cerebral hemorrhage after treatment with tissue plasminogen activator or streptokinase following embolic stroke in rabbits. Stroke, 1990, 21 : 1589-1593.
31. LYDEN P. D., ZIVIN J. A., CLARK W. A., MADDEN K., SASSE K. C. et al. Tissue plasminogen activator-mediated thrombolysis of cerebral emboli and its effect on hemorrhagic infarction in rabbits. Neurology, 1989, 39 : 703-708.
32. MARKS M. P., TONG D. C., BEAULIEU C., ALBERS G. W., DE CRESPIGNY A. et al. Evaluation of early reperfusion and i.v. tPA therapy using diffusion- and perfusion-weighted MRI. Neurology, 1999, 52 : 1792-1798.
33. MAKLER J. R., BROTT T., BRODERICK J., KOTHARI R., O'DONOGHUE M. et al. Tissue plasminogen activator for acute ischemic stroke. New Engl. J. Med., 1995, 333 : 1581-1587.
34. MASARYK T. J., TKACH J., GLICKLICH M. Flow, radiofrequency pulse sequences, and gradient magnetic fields : Basic interactions and adaptations to angiographic imaging. Top. Magn. Reson. Imaging, 1991, 3 : 1-11.
35. MATSUMOTO K., SATOH K. Topic intraarterial urokinase infusion for acute stroke. In : Thrombolytic Therapy in Acute Ischemic Stroke. HACKE W., DEL ZOPPO G. J., HIRSCHBERG M. (eds.). New York, Springer-Verlag, 1991, 207-212.
36. MORI E., YONEDA Y., TABUCHI M., YOSHIDA T., OHKAWA S. et al. Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke. Neurology, 1992, 42 : 976-982.
37. OKADA Y., SADOCHIMA S., KATSURAGI M., IRIE K., UTSUNOMIYA H., FUJISHIMA, M. Clinical and brain hemodynamic evaluations of thrombolytic therapy in acute ischemic stroke : SPECT study. In : Thrombolytic Therapy in Acute Ischemic Stroke. HACKE W., DEL ZOPPO G. J., HIRSCHBERG M. (eds.). New York, Springer-Verlag, 1993, 138-144.
38. OKADA Y., SADOSHIMA S., NAKANE H., UTSUNOMIYA H., FUJISMIMA M. Early computed tomographic findings for thrombolytic therapy in patients with acute brain embolism. Stroke, 1992, 23 : 20-23.
39. OKADA Y., YAMAGUCHI T., MINEMATSU K., MIYASHITA T., SAWADA T. et al. Hemorrhagic transformation in cerebral embolism. Stroke, 1989, 20 : 598-603.
40. OSSEMANN M., MORMONT E., MARIN V., JAMART J., LALOUX P. Identification des facteurs influençant le délai d'admission hospitalière après un accident vasculaire cérébral ischémique : étude d'une population rurale. Rev. Neurol., 2001 (in press).
41. OVERGAARD K., SEREGHY T., PEDERSEN H., BOYSEN G. Neuroprotection with NBQX and thrombolysis with rt-PA in rat embolic stroke. Neurol. Res., 1993a, 15 : 344-349.
42. OVERGAARD K., SEREGHY T., BOYSEN G., PEDERSEN H., DIEMER N. H. Reduction of infarct volume by thrombolysis with rt-PA in an embolic rat stroke model. Scand. J. Clin. Lab. Invest., 1993b, 53 : 383-393.
43. OVERGAARD K., SEREGHY T., FRELLSEN M., PEDERSEN H., HOYER S. et al. Composition of emboli influences the efficacy of thrombolysis with rt-PA in a rat stroke model. Fibrinolysis, 1993c, 7 : 141-148.
44. PHILLIPS D. A., FISCHER M., SMITH T. W., DAVIS M. A. Thrombolysis with t-PA after experimental stroke. Ann. Neurol., 1988, 23 : 391-394.
45. PULSINELLI W. The ischemic penumbra in stroke. Sci. Am. Sci. Med., 1995, 1 : 16-25.
46. RINGELSTEIN E. B., BINIEK R., WEILLER C., AMMELING B., NOLTE P. N. et al. Type and extent of hemispheric brain infarctions and clinical outcome in early and delayed middle cerebral artery recanalization. Neurology, 1992, 42 : 289-298.
47. RORDORF G., KOROSHETZ W. J., COPEN W. A., CRAMER S. C., SCHAERFER P. W. et al. Regional ischemia and ischemic injury in patients with acute middle cerebral artery stroke as defined by early diffusion-weighted and perfusion-weighted MRI. Stroke, 1998, 29 : 939-943.
48. RUGGIERI P. M., MASARYK T. T., ROSS J. S., MODIC M. T. Magnetic resonance angiography of the intracranial vasculature. Top. Magn. Reson. Imaging, 1991, 3 : 23-33.
49. SAKU Y., CHOKI J., WAKI R., MATSUDA J., FUJISHIMA M. et al. Hemorrhagic infarct induced by arterial hypertension in cat brain following middle cerebral artery occlusion. Stroke, 1990, 21 : 589-595.
50. SLOAN M. A. Thrombolysis and stroke. Past and future. Arch. Neurol., 1987, 44 : 748-768.
51. SLOAN M. A., PRICE T. R. Intracranial hemorrhage following thrombolytic therapy for acute myocardial infarction. Semin. Neurol., 1991, 11 : 385-399.
52. SUSSMAN B. J., FITCH T. S. P. Thrombolysis with fibrinolysin in cerebral arterial occlusion. J. Am. Med. Assoc., 1958, 167 : 1705-1709.
53. TANNE D., BATES V. E., VERRO P., KASNER S. E., BINDER J. R. et al. Initial clinical experience with IV tissue plasminogen activator for acute ischemic stroke : a multicenter survey. The t-PA Stroke Survey Group. Neurology, 1999, 53 : 424-427.
54. TONI D., FIORELLI M., BASTIANELLO S., SACCHETTI M. L., SETTE G. et al Hemorrhagic transformation of brain infarct : Predictability in the first 5 hours from stroke onset and influence on clinical outcome. Neurology, 1996, 46 : 341-345.
55. TONI D., FIORELLI M., GENTILE M., BASTIANELLO S., SACCHETTI M. L. et al Progressing neurological deficit secondary to acute ischemic stroke : A study on predictability, pathogenesis, and prognosis. Arch. Neurol., 1995, 52 : 670-675.
56. TROUILLAS P., NIGHOGHOSSIAN N., DEREX L., ADELEINE P., HONNORAT J. et al Thrombolysis with intravenous rtPA in a series of 100 cases of acute carotid territory stroke : determination of etiological, topographic, and radiological outcome factors. Stroke, 1998, 29 : 25292540.
57. TURPIE A. G., GENT M., LAUPACIS A., LATOUR Y., GUNSTENSEN J. et al A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement. N. Engl J. Med., 1993, 329 : 524-529.
58. TYSON G. W., TEASDALE G. M., GRAHAM D. I., MCCULLOCH J. Cerebrovascular permeability following MCA occlusion in the rat. The effect of halothane-induced hypotension. J. Neurosurg., 1982, 57 : 186-196.
59. UEDA T., SAKAKI S., KUMON Y., OHTA S. Multivariable analysis of predictive factors related to outcome at 6 months after intra-arterial thrombolysis for acute ischemic stroke. Stroke, 1999, 30 : 2360-2365.
60. VON KUMMER R., FORSTING M., SARTOR K., HACKE W. Intravenous recombinant tissue plasminogen activator in acute stroke. In : Thrombolytic Therapy in Acute Ischemic Stroke. HACKE, W., DEL ZOPPO G. J., HIRSCHBERG M. (eds.). New York, Springer-Verlag, 1991, 161-167.
61. VON KUMMER R., HACKE W. Safety and efficacy of intravenous tissue plasminogen activator and heparin in acute middle cerebral artery stroke. Stroke, 1992, 23 : 646-652.
62. VON KUMMER R., HOLLE R., ROSIN L., FORSTING M., HACKE W. Does arterial recanalization improve outcome in carotid territory stroke ? Stroke, 1995, 26 : 581-587.
63. VON KUMRNER R., MEYDING LAMADE U., FORSTING M., ROSIN L., RIEKE K. et al. Sensitivity and prognostic value of early CT in occlusion of the middle cerebral artery trunk. Am. J. Neuroradiol., 1994, 15 : 9-18.
64. WARACH S., DASHE J. F., EDELMAN R. R. Clinical outcome in ischemic stroke predicted by early diffusion-weighted and perfusion magnetic resonance imaging : A preliminary analysis. J. Cereb. Blood Flow Metab., 1996, 16 : 53-59.
65. WARACH S., LI W., RONTHAL M., EDELMAN R. R. Acute cerebral ischemia : evaluation with dynamic contrast-enhanced MR imaging and MR angiography. Radiology, 1992, 182 : 41-47.
66. WARDLAW J. M., DEL ZOPPO G., YAMAGUCHI T. Thrombolysis for acute ischemic stroke (Cochrane Review). The Cochrane Library (4). 1999. Oxford : Update Software.
67. WEISFELDT M. L. Reperfusion and reperfusion injury. Clin. Res., 1987, 35 : 13-20.
68. WOLPERT S. M., BRUCKMANN H., GREENLEE R., WECHSLER L., PESSIN M. S. et al. Neuroradiologic evaluation of patients with acute stroke treated with recombinant tissue plasminogen activator. Am. J. Neuroradiol., 1993, 14 : 3-13.
69. YARNAGUCHI T., HAYAKAWA T., KIUCHI H., for the Japanese Thrombolysis Study Group. Intravenous tissue plasminogen activator ameliorates the outcome of hyperacute embolie stroke. Cerebrovasc. Dis., 1993, 3 : 269-272.
70. YAMAGUCHI T., MINEMATSU K., CHOKI J. Arterial embolism. In : Cerebral Blood Flow : Physiologic and Clinical Aspects. WOOD J. H. (ed.). New York, McGraw-Hill 1987, 512-513.
71. ZIVIN J., LYDEN P. D., DEGIROLAMI U., KOCHHAR A., MAZZARELLA V. et al. Tissue plasminogen activa tor : reduction of neurologic damage after experimental embolic stroke. Arch. Neurol., 1988, 45 : 387-391.
72. ZIVIN J. A., FISCHER M., DEGIROLAMI U., HEMENWAY C. C., STASHAK K. A. Tissue plasminogen activator reduces neurological damage after cerebral embolism. Science, 1985, 230 : 1289-1292.
73. ZOCCHI M., MAZZANTI I., PISAPIA G., NUZZI R., RUSSO G. et al. Randomized controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke. Lancet, 1995, 346 : 1509-1514.